GB202208255D0 - Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity - Google Patents

Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Info

Publication number
GB202208255D0
GB202208255D0 GBGB2208255.6A GB202208255A GB202208255D0 GB 202208255 D0 GB202208255 D0 GB 202208255D0 GB 202208255 A GB202208255 A GB 202208255A GB 202208255 D0 GB202208255 D0 GB 202208255D0
Authority
GB
United Kingdom
Prior art keywords
autoimmunity
inflammation
diseases
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2208255.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acacia Health Ltd
Original Assignee
Acacia Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acacia Health Ltd filed Critical Acacia Health Ltd
Priority to GBGB2208255.6A priority Critical patent/GB202208255D0/en
Publication of GB202208255D0 publication Critical patent/GB202208255D0/en
Ceased legal-status Critical Current

Links

GBGB2208255.6A 2022-06-06 2022-06-06 Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity Ceased GB202208255D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2208255.6A GB202208255D0 (en) 2022-06-06 2022-06-06 Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2208255.6A GB202208255D0 (en) 2022-06-06 2022-06-06 Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Publications (1)

Publication Number Publication Date
GB202208255D0 true GB202208255D0 (en) 2022-07-20

Family

ID=82404551

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2208255.6A Ceased GB202208255D0 (en) 2022-06-06 2022-06-06 Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Country Status (1)

Country Link
GB (1) GB202208255D0 (en)

Similar Documents

Publication Publication Date Title
GB202211273D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
EP4149482A4 (en) 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
EP3969125A4 (en) Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
ZA202110225B (en) Plant extract mixture for use in the prevention and/or treatment of chronic inflammatory bowel diseases
PL3937948T3 (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
GB202217453D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208255D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208256D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
EP4232066A4 (en) Polypeptides for use in the treatment and prevention of neurodegenerative diseases
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease
GB2610895C (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202211274D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GB202202541D0 (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202304262D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202207559D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
IL284298A (en) Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases
GB202217454D0 (en) Compounds for use in the treatment of diseases and conditions associated with anxiety and / or mood disorders
AU2023244447A1 (en) 5-meo-dmt for use in the treatment of sleep disturbance
AU2021381054A9 (en) Pharmaceutical compositions for use in the management and treatment of pain
GB202409801D0 (en) Products for use in the treatment and prevention of allergy and associated lung conditions/diseases
EP4046658A4 (en) Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)